These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20055823)

  • 1. A curious but non-serious local side effect of inhaled iloprost: sudden linear erythematous facial rash.
    Feito Rodríguez M; Floristan U; de Lucas Laguna R
    Clin Exp Dermatol; 2009 Dec; 34(8):e1014. PubMed ID: 20055823
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it safe to use inhaled iloprost in infants with pulmonary hypertension?
    Karaagaç AT; Yildirim AI
    Indian Pediatr; 2013 Nov; 50(11):1064-5. PubMed ID: 24382910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 4. Iloprost-induced rash.
    Finn RS; Beckert L; Troughton R
    Thorax; 2009 Oct; 64(10):917-8. PubMed ID: 19786719
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled iloprost in pulmonary arterial hypertension.
    Baker SE; Hockman RH
    Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
    Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
    Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.
    Halank M; Marx C; Miehlke S; Hoeffken G
    J Gastroenterol; 2004 Dec; 39(12):1222-3. PubMed ID: 15622492
    [No Abstract]   [Full Text] [Related]  

  • 9. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary arterial hypertension and inhaled iloprost: good night rebound effects?
    Domenighetti GM
    Respiration; 2007; 74(5):496-7. PubMed ID: 17671405
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension.
    Cotrim C; Simões O; Loureiro MJ; Cordeiro P; Miranda R; Silva C; Avillez T; Carrageta M
    Rev Port Cardiol; 2006 May; 25(5):529-33. PubMed ID: 16910160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled iloprost in lung transplantation: can it avoid extracorporeal circulation in patients with severe pulmonary hypertension?
    Winterhalter M; Simon A; Fischer S; Gras C; Zuk J; Piepenbrock S; Strüber M
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):716-8. PubMed ID: 17023296
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK; Madsen S; Kjekshus J; Simonsen S
    Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized iloprost for primary pulmonary hypertension.
    Ewert R; Wensel R; Opitz CF
    N Engl J Med; 2000 Nov; 343(19):1421-2. PubMed ID: 11183891
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension.
    Tissières P; Nicod L; Barazzone-Argiroffo C; Rimensberger PC; Beghetti M
    Ann Thorac Surg; 2004 Sep; 78(3):e48-50. PubMed ID: 15337084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases.
    Ioannides D; Lazaridou E; Apalla Z; Devliotou-Panagiotidou D
    Br J Dermatol; 2009 Mar; 160(3):719-20. PubMed ID: 19175601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.